BACKGROUND: Retroperitoneal sarcomas historically have presented difficulties in their management due to a high rate of unresectability, which affects the survival of these patients. METHODS: We retrospectively reviewed the charts of 87 consecutive patients with retroperitoneal sarcomas treated in the period 1977-1994. RESULTS: The resectability rate was 100% for the primary tumors (n = 55) and 87% for the locally recurrent tumors (n = 32). The 5-year survival rate was 63% (66% for the primary tumors and 57% for those with local recurrence). The 10-year survival rate was 46% (57% for primary tumors and 26% for those referred with locally recurrent tumor). The overall local recurrence rate was 31% (25% for the primary tumors and 41% for those referred with local recurrence); it was 56% after local excision and 15% after wide resection (p = 0.0003). The 10-year disease-free survival of patients with local excision (n = 25) was 7%, and that of patients with wide resection (n = 54) 59% (p = 0.0001). CONCLUSIONS: The overall resectability rate of retroperitoneal sarcomas was 95%. Wide resection produced a significantly higher survival rate compared with that of local excision. The survival rate for the primary tumors, varying significantly with the histologic grade, approached the rate reported for primary soft-tissue sarcomas of the extremity.
BACKGROUND:Retroperitoneal sarcomas historically have presented difficulties in their management due to a high rate of unresectability, which affects the survival of these patients. METHODS: We retrospectively reviewed the charts of 87 consecutive patients with retroperitoneal sarcomas treated in the period 1977-1994. RESULTS: The resectability rate was 100% for the primary tumors (n = 55) and 87% for the locally recurrent tumors (n = 32). The 5-year survival rate was 63% (66% for the primary tumors and 57% for those with local recurrence). The 10-year survival rate was 46% (57% for primary tumors and 26% for those referred with locally recurrent tumor). The overall local recurrence rate was 31% (25% for the primary tumors and 41% for those referred with local recurrence); it was 56% after local excision and 15% after wide resection (p = 0.0003). The 10-year disease-free survival of patients with local excision (n = 25) was 7%, and that of patients with wide resection (n = 54) 59% (p = 0.0001). CONCLUSIONS: The overall resectability rate of retroperitoneal sarcomas was 95%. Wide resection produced a significantly higher survival rate compared with that of local excision. The survival rate for the primary tumors, varying significantly with the histologic grade, approached the rate reported for primary soft-tissue sarcomas of the extremity.
Authors: J Glenn; W F Sindelar; T Kinsella; E Glatstein; J Tepper; J Costa; A Baker; P Sugarbaker; M F Brennan; C Seipp Journal: Surgery Date: 1985-03 Impact factor: 3.982
Authors: D A Potter; T Kinsella; E Glatstein; R Wesley; D E White; C A Seipp; A E Chang; E E Lack; J Costa; S A Rosenberg Journal: Cancer Date: 1986-07-01 Impact factor: 6.860
Authors: Alexandra M Koenig; Matthias Reeh; Christoph M Burdelski; Claudia Wengert; Karim A Gawad; Jakob R Izbicki; Maximilian Bockhorn Journal: Langenbecks Arch Surg Date: 2012-03-10 Impact factor: 3.445
Authors: Marco Milone; Luigi Sossio Pezzullo; Giuseppe Salvatore; Martina Gilda Pezzullo; Maddalena Leongito; Ida Esposito; Francesco Milone Journal: Updates Surg Date: 2011-04-01
Authors: Antonio Chiappa; Emilio Bertani; Gabriella Pravettoni; Andrew Paul Zbar; Diego Foschi; Giuseppe Spinoglio; Bernardo Bonanni; Gianluca Polvani; Federico Ambrogi; Maria Laura Cossu; Carlo Ferrari; Marco Venturino; Cristiano Crosta; Luca Bocciolone; Roberto Biffi Journal: Indian J Surg Date: 2018-01-31 Impact factor: 0.656
Authors: Imran Hassan; Saung Z Park; John H Donohue; David M Nagorney; Paul A Kay; Antonio G Nasciemento; Cathy D Schleck; Duane M Ilstrup Journal: Ann Surg Date: 2004-02 Impact factor: 12.969
Authors: Timothy M Zagar; Robert R Shenk; Julian A Kim; Deb Harpp; Charles A Kunos; Fadi W Abdul-Karim; William C Chen; Yuji Seo; Timothy J Kinsella Journal: J Oncol Date: 2009-01-29 Impact factor: 4.375